{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:14:36Z","timestamp":1785773676174,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mtna.2016.11","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T12:25:02Z","timestamp":1458044702000},"page":"e295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA"],"prefix":"10.1016","volume":"5","author":[{"given":"Zhengyang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yange","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2016.11_bib1","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"key":"10.1038\/mtna.2016.11_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/656624","article-title":"Review of hepatitis B therapeutics","volume":"51","author":"Bhattacharya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1038\/mtna.2016.11_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cld.2007.08.002","article-title":"Molecular virology of hepatitis B virus for clinicians","volume":"11","author":"Block","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1038\/mtna.2016.11_bib4","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/onc.2010.36","article-title":"Viral hepatocarcinogenesis","volume":"29","author":"Tsai","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/mtna.2016.11_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3851\/IMP1798","article-title":"RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study","volume":"16","author":"Gish","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1038\/mtna.2016.11_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1038\/mtna.2016.11_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1096\/fasebj.14.9.1041","article-title":"Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future","volume":"14","author":"Ray","year":"2000","journal-title":"FASEB J"},{"key":"10.1038\/mtna.2016.11_bib8","first-page":"89","article-title":"An introduction to peptide nucleic acid","volume":"1","author":"Nielsen","year":"1999","journal-title":"Curr Issues Mol Biol"},{"key":"10.1038\/mtna.2016.11_bib9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.ejhg.5201226","article-title":"The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics","volume":"12","author":"Pellestor","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/mtna.2016.11_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biomaterials.2011.09.075","article-title":"Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene","volume":"33","author":"Bai","year":"2012","journal-title":"Biomaterials"},{"key":"10.1038\/mtna.2016.11_bib11","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1111\/j.1365-2893.2010.01416.x","article-title":"Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA","volume":"18","author":"Ahn","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1038\/mtna.2016.11_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jhep.2004.10.010","article-title":"Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA)","volume":"42","author":"Robaczewska","year":"2005","journal-title":"J Hepatol"},{"key":"10.1038\/mtna.2016.11_bib13","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1093\/nar\/gki991","article-title":"Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells","volume":"33","author":"Turner","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.11_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/jvi.70.1.585-589.1996","article-title":"Specific hepatitis B virus minus-strand DNA synthesis requires only the 5\u2032 encapsidation signal and the 3\u2032-proximal direct repeat DR1","volume":"70","author":"Rieger","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mtna.2016.11_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2893.1996.tb00047.x","article-title":"Hepatitis B virus replication'an update","volume":"3","author":"Nassal","year":"1996","journal-title":"J Viral Hepat"},{"key":"10.1038\/mtna.2016.11_bib16","first-page":"29","article-title":"Solid phase synthesis of PNA oligomers","volume":"208","author":"Beck","year":"2002","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mtna.2016.11_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/bc050283q","article-title":"Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA)","volume":"17","author":"Bendifallah","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1038\/mtna.2016.11_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/mz5001916","article-title":"Self-assembly of hybridized peptide nucleic acid amphiphiles","volume":"3","author":"Liu","year":"2014","journal-title":"Acs Macro Lett"},{"key":"10.1038\/mtna.2016.11_bib19","doi-asserted-by":"crossref","first-page":"26204","DOI":"10.1074\/jbc.M010625200","article-title":"Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells","volume":"276","author":"Eguchi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2016.11_bib20","doi-asserted-by":"crossref","first-page":"34141","DOI":"10.1074\/jbc.M303045200","article-title":"Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins","volume":"278","author":"Fittipaldi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2016.11_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/mtna.2016.11_bib22","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.11_bib23","doi-asserted-by":"crossref","first-page":"30181","DOI":"10.1074\/jbc.M112.370312","article-title":"Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4\u03b1 in vitro and in vivo","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2016.11_bib24","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.11_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1499-3872(11)60049-0","article-title":"Evaluation of hepatitis B viral replication and proteomic analysis of HepG2.2.15 cell line after knockdown of HBx","volume":"10","author":"Xie","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1038\/mtna.2016.11_bib26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J Hepatol"},{"key":"10.1038\/mtna.2016.11_bib27","first-page":"75","article-title":"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis","volume":"103","author":"Benhenda","year":"2009","journal-title":"Adv Cancer Res"},{"key":"10.1038\/mtna.2016.11_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4149\/av_2012_01_49","article-title":"Inhibition of hepatitis B virus gene expression by small interfering RNAs targeting cccDNA and X antigen","volume":"56","author":"Xie","year":"2012","journal-title":"Acta Virol"},{"key":"10.1038\/mtna.2016.11_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/mt.2013.31","article-title":"Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection","volume":"21","author":"Wooddell","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.11_bib30","first-page":"43","article-title":"Synthesis of PNA-peptide conjugates","volume":"208","author":"Awasthi","year":"2002","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mtna.2016.11_bib31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1039\/b901979k","article-title":"Thiol-click chemistry: a multifaceted toolbox for small molecule and polymer synthesis","volume":"39","author":"Hoyle","year":"2010","journal-title":"Chem Soc Rev"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:26:27Z","timestamp":1761873987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253117300240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"alternative-id":["S2162253117300240"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2016.11","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mtna.2016.11","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Official journal of the American Society of Gene & Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e295"}}